Berberine in the treatment of type 2 diabetes - literature review

Aleksandra Mazurek, Mateusz Pawlicki, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Kłos, Wiktoria Wilanowska
{"title":"Berberine in the treatment of type 2 diabetes - literature review","authors":"Aleksandra Mazurek, Mateusz Pawlicki, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Kłos, Wiktoria Wilanowska","doi":"10.12775/jehs.2024.67.49000","DOIUrl":null,"url":null,"abstract":"Introduction and purpose :  \nType 2 diabetes is currently a serious problem worldwide. Each year, the number of individuals with carbohydrate metabolism disorders is increasing. This is due to an unhealthy lifestyle, lack of physical activity, and a diet rich in highly processed foods. Currently, the treatment of type 2 diabetes is based on the use of oral antidiabetic medications, with the first choice often being a derivative of biguanides, such as metformin. Berberine has been used in China for many years as a hypoglycemic agent, and its efficacy is compared to metformin preparations. This paper focuses on the benefits of using berberine in patients with prediabetes or type 2 diabetes and compares the effects of berberine preparations to classical medications used in diabetes treatment.  \n  \nMaterial and methods :   \nThe literaue was reviewed in PubMed and Google Scholar scientific database in 2013-2023 using the following keywords : berberine, diabetes mellitus type 2, hyperlipidemia, hyperglicemia    \nConclusions :  \nThe studies included in this manuscript have shown that berberine is a promising agent for adjunctive treatment in type 2 diabetes. It exhibits a range of positive effects such as lowering blood glucose levels, improving lipid profile, with no serious adverse effects reported. However, further research is needed to confirm these findings and develop an effective treatment plan. ","PeriodicalId":15567,"journal":{"name":"Journal of Education, Health and Sport","volume":"108 37","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Education, Health and Sport","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12775/jehs.2024.67.49000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and purpose :  Type 2 diabetes is currently a serious problem worldwide. Each year, the number of individuals with carbohydrate metabolism disorders is increasing. This is due to an unhealthy lifestyle, lack of physical activity, and a diet rich in highly processed foods. Currently, the treatment of type 2 diabetes is based on the use of oral antidiabetic medications, with the first choice often being a derivative of biguanides, such as metformin. Berberine has been used in China for many years as a hypoglycemic agent, and its efficacy is compared to metformin preparations. This paper focuses on the benefits of using berberine in patients with prediabetes or type 2 diabetes and compares the effects of berberine preparations to classical medications used in diabetes treatment.    Material and methods :   The literaue was reviewed in PubMed and Google Scholar scientific database in 2013-2023 using the following keywords : berberine, diabetes mellitus type 2, hyperlipidemia, hyperglicemia    Conclusions :  The studies included in this manuscript have shown that berberine is a promising agent for adjunctive treatment in type 2 diabetes. It exhibits a range of positive effects such as lowering blood glucose levels, improving lipid profile, with no serious adverse effects reported. However, further research is needed to confirm these findings and develop an effective treatment plan. 
小檗碱治疗 2 型糖尿病--文献综述
导言和目的:2 型糖尿病是目前全球范围内的一个严重问题。每年,患有碳水化合物代谢紊乱的人数都在增加。这是由于不健康的生活方式、缺乏体育锻炼以及饮食中富含高度加工食品造成的。目前,2 型糖尿病的治疗主要依靠口服抗糖尿病药物,首选药物通常是双胍类药物的衍生物,如二甲双胍。小檗碱作为降糖药在中国已使用多年,其疗效可与二甲双胍制剂进行比较。本文重点探讨了小檗碱对糖尿病前期或 2 型糖尿病患者的益处,并比较了小檗碱制剂与治疗糖尿病的传统药物的疗效。 材料和方法:2013-2023 年,在 PubMed 和谷歌学术科学数据库中查阅了相关文献,关键词为:小檗碱、2 型糖尿病、高脂血症、高胆固醇血症: 本手稿中的研究表明,小檗碱是一种很有前景的 2 型糖尿病辅助治疗药物。它具有一系列积极作用,如降低血糖水平、改善血脂状况,且无严重不良反应报告。然而,要证实这些发现并制定有效的治疗方案,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信